BC Platforms, a world leader in genomic data management solutions, today announces that it has closed a $USD 10 million financing round. The round was led by Debiopharm Innovation Fund in conjunction with Tesi, a Finnish venture capital and private equity company, and was supported by BC Platforms’ existing investors. BC Platforms will use the funds to launch new technologies in 2017 integrating complex clinical and genomic data in order to deliver precision medicine and clinical patient benefits, as well as to grow its existing genomic data management software business worldwide.
To date, the company has established partnerships with over 50 enterprise level Healthcare units and biobanks globally in 19 countries representing more than 2 million subjects.BC Platforms’ vision is to provide the world’s leading analytics platform for healthcare and industry, with access by 2020 to over 5 million subjects’ diverse genomic and clinical data and samples consolidated from a global network of biobanks. Biobanks are organized repositories of human biological material and associated data stored for research purposes. BC Platforms partners with biobanks to aggregate these data for analysis to provide transformative solutions for customers across all therapeutic areas and along the entire product development life cycle.
Read the entire article here